231 related articles for article (PubMed ID: 23519781)
21. Relevance of Notch Signaling for Bone Metabolism and Regeneration.
Ballhause TM; Jiang S; Baranowsky A; Brandt S; Mertens PR; Frosch KH; Yorgan T; Keller J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572704
[TBL] [Abstract][Full Text] [Related]
22. Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing.
Dishowitz MI; Mutyaba PL; Takacs JD; Barr AM; Engiles JB; Ahn J; Hankenson KD
PLoS One; 2013; 8(7):e68726. PubMed ID: 23844237
[TBL] [Abstract][Full Text] [Related]
23. Notch signaling in human development and disease.
Penton AL; Leonard LD; Spinner NB
Semin Cell Dev Biol; 2012 Jun; 23(4):450-7. PubMed ID: 22306179
[TBL] [Abstract][Full Text] [Related]
24. Notch and the regulation of osteoclast differentiation and function.
Yu J; Canalis E
Bone; 2020 Sep; 138():115474. PubMed ID: 32526405
[TBL] [Abstract][Full Text] [Related]
25. [Notch signaling in bone formation and related skeletal diseases].
Ma H; Wu Y; Zhang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):274-9. PubMed ID: 25863103
[TBL] [Abstract][Full Text] [Related]
26. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
[TBL] [Abstract][Full Text] [Related]
27. Role of notch signaling in osteoimmunology--from the standpoint of osteoclast differentiation.
Duan L; Ren Y
Eur J Orthod; 2013 Apr; 35(2):175-82. PubMed ID: 22423182
[TBL] [Abstract][Full Text] [Related]
28. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.
Dvorak-Ewell MM; Chen TH; Liang N; Garvey C; Liu B; Tu C; Chang W; Bikle DD; Shoback DM
J Bone Miner Res; 2011 Dec; 26(12):2935-47. PubMed ID: 21956637
[TBL] [Abstract][Full Text] [Related]
29. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.
Yang T; Grafe I; Bae Y; Chen S; Chen Y; Bertin TK; Jiang MM; Ambrose CG; Lee B
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7336-41. PubMed ID: 23589896
[TBL] [Abstract][Full Text] [Related]
30. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
Canalis E; Sanjay A; Yu J; Zanotti S
Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
[TBL] [Abstract][Full Text] [Related]
31. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
32. The role of small leucine zipper protein in osteoclastogenesis and its involvement in bone remodeling.
Kim S; Park S; Kang M; Ko J
Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118827. PubMed ID: 32822727
[TBL] [Abstract][Full Text] [Related]
33. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients.
Lisignoli G; Piacentini A; Cristino S; Grassi F; Cavallo C; Cattini L; Tonnarelli B; Manferdini C; Facchini A
J Cell Physiol; 2007 Mar; 210(3):798-806. PubMed ID: 17133360
[TBL] [Abstract][Full Text] [Related]
34. Osteoporosis: a neuroskeletal disease?
Takeda S
Int J Biochem Cell Biol; 2009 Mar; 41(3):455-9. PubMed ID: 18761104
[TBL] [Abstract][Full Text] [Related]
35. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
[TBL] [Abstract][Full Text] [Related]
36. NOTCHing the bone: insights into multi-functionality.
Engin F; Lee B
Bone; 2010 Feb; 46(2):274-80. PubMed ID: 19520195
[TBL] [Abstract][Full Text] [Related]
37. Thrombospondins in bone remodeling and metastatic bone disease.
Carminati L; Taraboletti G
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C980-C990. PubMed ID: 32936697
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling inhibition protects against LPS mediated osteolysis.
Goel PN; Egol AJ; Moharrer Y; Brandfield-Harvey B; Ahn J; Ashley JW
Biochem Biophys Res Commun; 2019 Aug; 515(4):538-543. PubMed ID: 31176486
[TBL] [Abstract][Full Text] [Related]
39. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
Kim HJ; Minashima T; McCarthy EF; Winkles JA; Kirsch T
J Bone Miner Res; 2010 Aug; 25(8):1771-83. PubMed ID: 20200976
[TBL] [Abstract][Full Text] [Related]
40. Bone metabolism regulation: Implications for the treatment of bone diseases.
Yao D; Huang L; Ke J; Zhang M; Xiao Q; Zhu X
Biomed Pharmacother; 2020 Sep; 129():110494. PubMed ID: 32887023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
